Kiniksa Pharmaceuticals
KNSA
KNSA
92 hedge funds and large institutions have $290M invested in Kiniksa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 96 → 92 (-4)
5% less capital invested
Capital invested by funds: $306M → $290M (-$15.5M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
92
Holding in Top 10
1
Calls
$3.32M
Puts
$1.55M
Top Buyers
| 1 | +$5.07M | |
| 2 | +$3.23M | |
| 3 | +$1.88M | |
| 4 |
Morgan Stanley
New York
|
+$1.81M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.13M |
Top Sellers
| 1 | -$7.04M | |
| 2 | -$3.28M | |
| 3 | -$3.12M | |
| 4 |
Goldman Sachs
New York
|
-$2.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.89M |